Drug Safety :: Lilly’s CEO Calls for Reform of Nation’s Drug Safety System

Sidney Taurel, chairman and chief executive officer, Eli Lilly and Company (NYSE: LLY), in a speech at the Cleveland Clinic, called on the health care industry, medical community and U.S. government to actively collaborate on a health information technology system that would provide more rapid and useful insights on the effectiveness of medicines while improving drug safety.